Navigation Links
NPS Reports Successful GATTEX(TM) Extension Study
Date:3/17/2008

the third quarter of this year."

Phase 3-Extension Study Design

The extension study enrolled 65 of the 71 patients (91%) patients who had previously completed a Phase 3 clinical trial that evaluated low-dose GATTEX (0.05 mg/kg/day), high-dose GATTEX (0.10 mg/kg/day) and placebo for PN-dependent SBS patients. Patients who were already receiving GATTEX in the Phase 3 study continued on their dose for an additional 28 weeks for a total of 52 weeks of therapy. Patients who were receiving placebo in the initial Phase 3 clinical study were randomized in the blinded extension study to receive either a low dose of GATTEX (0.05 mg/kg/day) or a high dose of GATTEX (0.10 mg/kg/day) for 28 weeks of therapy.

Previously Reported Phase 3 Results

In October 2007, NPS reported positive top-line results from the company's Phase 3 study of GATTEX in which 83 patients with short bowel syndrome (SBS) received either a low dose of GATTEX (0.05 milligrams/kilogram/day), a higher dose (0.10 mg/kg/day) or placebo. The clinical efficacy endpoint of the study was a reduction in PN of at least 20% comparing baseline to weeks 20 to 24, measured as a graded response to capture reductions up to 100%. In an intent-to-treat analysis, forty-six percent (46%) of patients receiving the lower dose of GATTEX (N=35) responded and achieved a significant reduction in PN compared to placebo (p=0.007). Twenty-five percent (25%) of patients receiving the higher dose of GATTEX (N=32) responded and showed a trend in the difference between the treatment group and placebo, but this did not reach statistical significance (p=0.161). Two low-dose patients gained independence from and discontinued PN by week 16 and a third high-dose patient discontinued PN at the end of treatment. The study's criteria for conducting the statistical analysis of the primary endpoint required that the results for the high-dose group show statistical significance before the results of the low-dose group could
'/>"/>

SOURCE NPS Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. Spherix Reports Second Quarter Earnings
3. Tapestry Reports Second Quarter 2007 Results
4. Callisto Reports on Second-Quarter 2007 Milestones
5. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
6. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
7. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
8. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
9. Biopure Reports on Meeting with the FDA
10. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
11. NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Aug. 21, 2014 Nektar Therapeutics (NASDAQ: ... today announced positive results from its Phase 3 ... extended half-life recombinant factor VIII (rFVIII) treatment for ... which met its primary endpoint in reducing annualized ... to the on-demand arm. Top-line results ...
(Date:8/21/2014)... Canadian Epilepsy Alliance (CEA) is thrilled to announce the launch ... the most common neurological disorder in Canada ... tells a fictional story based on the experiences of 14-year-old ... "Despite the fact that epilepsy affects 1 ... lack of awareness out there," says Gail Dempsey , ...
(Date:8/21/2014)... percent of Americans believe the abuse of strong prescription pain ... safety issue in the United States , ... & Partners, a Cincinnati based research ... the prescription medication abuse problem and the need for medical ... facing our country," Rex Repass , CEO of the ...
Breaking Medicine Technology:Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 2Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 3Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 5Action Heroes Harness Powers to Educate Children About Epilepsy 2Action Heroes Harness Powers to Educate Children About Epilepsy 3Consumers Desperate For Measures To Curb Prescription Drug Abuse 2Consumers Desperate For Measures To Curb Prescription Drug Abuse 3
... 2011 ORTHOCON, Inc., a privately-held therapeutic device ... worldwide license agreement with Bezwada Biomedical to develop ... Bezwada Biomedical is an innovation-driven company ... biocompatible polyurethanes and polyamides derived from hydrolyzable isocyanates. ...
... Caliper Life Sciences, Inc. (NASDAQ: CALP ... Spectrum CT , a breakthrough preclinical imaging system that ... and low dose microCT (micro computed tomography).  Spectrum CT ... with vital, unparalleled insights into complex biological systems in ...
Cached Medicine Technology:ORTHOCON Announces Signing of Exclusive, Worldwide License Agreement With Bezwada Biomedical 2Caliper Life Sciences Announces IVIS Spectrum CT 2Caliper Life Sciences Announces IVIS Spectrum CT 3
(Date:8/22/2014)... Reacting to naysayers who are being skeptical about the ... PRP therapy LA specialist has firmly stated that the ... practical well researched science and nothing to do with ... medical breakthrough technology which focuses on healing and repair ... , The Managing Director of one of the top ...
(Date:8/22/2014)... 22, 2014 Teen substance abuse has ... OH. Unfortunately, most young adults never receive the professional ... the community, the new Troubled Teens Columbus helpline was ... to overcome their drug and alcohol dependencies . ... teens and their parents can speak directly to a ...
(Date:8/22/2014)... 2014 Aid in Recovery, a full ... today regarding a recent bill introduced in ... a current legislator and retired police general. In House ... related offenders, rather than imprisonment. Aid in Recovery points ... solution for the drug addiction epidemic. , The bill, ...
(Date:8/21/2014)... August 22, 2014 Yoga Darshana Center, ... Island region, proudly announces the launch of their newest ... the West Babylon-based yoga studio’s new teacher training program, ... become teachers realize their dreams. , Since 2001, Yoga ... living in the surrounding area a place to learn ...
(Date:8/21/2014)... UWDress.com, a well-known wedding dress manufacturer, has added ... its online store. In addition to this, all these beautiful ... percent off) at the moment. The special offer will last ... kind online workers have updated its online category with these ... company’s website is a one stop place where worldwide people ...
Breaking Medicine News(10 mins):Health News:MetroMD With The Help Of PRP Therapy Helps People Fight Hip Injuries 2Health News:New Helpline in Columbus Assists Troubled Teen Find Youth Rehab 2Health News:Proposed Legislature in the Philippines Highlights the Need for Rehabilitation, Not Incarceration, for Drug Users, Says Aid in Recovery 2Health News:Proposed Legislature in the Philippines Highlights the Need for Rehabilitation, Not Incarceration, for Drug Users, Says Aid in Recovery 3Health News:Yoga Darshana Center Announces Launch of New Website LongIslandYogaTeacherTraining.com 2Health News:Beautiful Peacock Party Dresses for 2014 Offered by UWDress.com at the Moment 2
... and eventually eliminate cancer disparities among adults in the Philadelphia ... established the Center to Eliminate Cancer Disparities . ... oncologist at Thomas Jefferson University Hospital and Clinical ... Medical Oncology at Jefferson Medical College of Thomas Jefferson University, ...
... HealthDay Reporter , THURSDAY, Feb. 16 (HealthDay News) -- ... hidden source of arsenic, new research suggests. Researchers at ... syrup, is found in some infant formulas. Their report appears ... . Arsenic is a natural element that can contaminate ...
... program designed to support self-management and improve overall ... tested painACTION.com,s ability to increase the use of ... A total of 185 participants completed the study. ... they could prevent headaches and manage headache-related pain ...
... , WEDNESDAY, Feb. 15 (HealthDay News) -- Researchers have discovered ... of cases of inherited dilated cardiomyopathy, a serious heart muscle ... In the study, published in the Feb. 16 issue ... analyzed the DNA of 312 people with dilated cardiomyopathy, 231 ...
... than half of women with rheumatoid arthritis (RA) and systemic ... choice has some influence on the smaller family size, findings ... journal of the American College of Rheumatology (ACR), suggest that ... number of offspring born to women with these chronic conditions. ...
... , WEDNESDAY, Feb. 15 (HealthDay News) -- The quit-smoking ... alcohol consumption, a small new study suggests. ... understood, but its use may increase blood pressure, heart ... the pleasurable effects of alcohol, the researchers said. ...
Cached Medicine News:Health News:Jefferson's Kimmel Cancer Center establishes Center to Eliminate Cancer Disparities 2Health News:Jefferson's Kimmel Cancer Center establishes Center to Eliminate Cancer Disparities 3Health News:Arsenic Might Be Found in Some Organic Foods: Study 2Health News:Arsenic Might Be Found in Some Organic Foods: Study 3Health News:painACTION.com improves migraine self-management and reduces migraine-related psychological distress 2Health News:Study Finds Gene Behind Inherited Cases of Enlarged Heart 2Health News:Study Finds Gene Behind Inherited Cases of Enlarged Heart 3Health News:Women with rheumatoid arthritis and lupus give birth to fewer children 2Health News:Stop-Smoking Drug May Also Curb Problem Drinking 2
... Our ELISA products for autoimmune testing ... ELISAs, as well as specific reflex tests ... Sm, Sm/RNP, SS-A (Ro), SS-B (La), Scl-70 ... family includes a full line of products ...
... for autoimmune testing feature single-well ANA screen ... specific reflex tests including dsDNA, and 6 ... SS-B (La), Scl-70 and Jo-1. In addition, ... line of products for Cardiolipins (IgA, IgG, ...
... for autoimmune testing feature single-well ANA screen ... specific reflex tests including dsDNA, and 6 ... SS-B (La), Scl-70 and Jo-1. In addition, ... line of products for Cardiolipins (IgA, IgG, ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: